190 related articles for article (PubMed ID: 7841184)
1. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
Lappalainen K; Urtti A; Söderling E; Jääskeläinen I; Syrjänen K; Syrjänen S
Biochim Biophys Acta; 1994 Dec; 1196(2):201-8. PubMed ID: 7841184
[TBL] [Abstract][Full Text] [Related]
2. Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
Ollikainen H; Lappalainen K; Jääskeläinen I; Syrjänen S; Pulkki K
Leuk Lymphoma; 1996 Dec; 24(1-2):165-74. PubMed ID: 9049973
[TBL] [Abstract][Full Text] [Related]
3. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study.
Lappalainen K; Miettinen R; Kellokoski J; Jääskeläinen I; Syrjänen S
J Histochem Cytochem; 1997 Feb; 45(2):265-74. PubMed ID: 9016315
[TBL] [Abstract][Full Text] [Related]
4. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide-cationic liposome interactions. A physicochemical study.
Jääskeläinen I; Mönkkönen J; Urtti A
Biochim Biophys Acta; 1994 Oct; 1195(1):115-23. PubMed ID: 7918553
[TBL] [Abstract][Full Text] [Related]
6. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
[TBL] [Abstract][Full Text] [Related]
7. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.
Islam A; Handley SL; Thompson KS; Akhtar S
J Drug Target; 2000; 7(5):373-82. PubMed ID: 10721799
[TBL] [Abstract][Full Text] [Related]
8. [Drug delivery system (DDS) for the use of antisense oligodeoxynucleotide phosphorothioate in controlling gene expression].
Maeda N; Miyano-Kurosaki N; Yamamoto N
Nihon Rinsho; 1998 Mar; 56(3):686-90. PubMed ID: 9549357
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
[TBL] [Abstract][Full Text] [Related]
10. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells.
Filion MC; Phillips NC
Biochim Biophys Acta; 1997 Oct; 1329(2):345-56. PubMed ID: 9371426
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cell proliferation and toxicity assays using two cationic liposomes.
Lappalainen K; Jääskeläinen I; Syrjänen K; Urtti A; Syrjänen S
Pharm Res; 1994 Aug; 11(8):1127-31. PubMed ID: 7971713
[TBL] [Abstract][Full Text] [Related]
13. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides.
Jääskeläinen I; Peltola S; Honkakoski P; Mönkkönen J; Urtti A
Eur J Pharm Sci; 2000 May; 10(3):187-93. PubMed ID: 10767596
[TBL] [Abstract][Full Text] [Related]
14. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
Lewis JG; Lin KY; Kothavale A; Flanagan WM; Matteucci MD; DePrince RB; Mook RA; Hendren RW; Wagner RW
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3176-81. PubMed ID: 8622909
[TBL] [Abstract][Full Text] [Related]
15. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
[TBL] [Abstract][Full Text] [Related]
16. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
18. Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide.
Noguchi S; Hirashima N; Furuno T; Nakanishi M
J Control Release; 2003 Mar; 88(2):313-20. PubMed ID: 12628337
[TBL] [Abstract][Full Text] [Related]
19. The effect of beta-tubulin-specific antisense oligonucleotide encapsulated in different cationic liposomes on the suppression [correction of supression] of intracellular L. donovani parasites in vitro.
Dasgupta D; Adhya S; Basu MK
J Biochem; 2002 Jul; 132(1):23-7. PubMed ID: 12097156
[TBL] [Abstract][Full Text] [Related]
20. Intracellular delivery of oligonucleotides in Helicobacter pylori by fusogenic liposomes in the presence of gastric mucus.
Santos RS; Dakwar GR; Zagato E; Brans T; Figueiredo C; Raemdonck K; Azevedo NF; De Smedt SC; Braeckmans K
Biomaterials; 2017 Sep; 138():1-12. PubMed ID: 28550752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
